Kura Oncology
Patents, Design & Utilities

Last updated:

List of all Kura Oncology patents 25 in total

Status Patent
Application
Utility: METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 2 Jun 2022
Application
Utility: METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 12 May 2022
Application
Utility: METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 12 May 2022
Application
Utility: METHODS OF TREATING SQUAMOUS CELL CARCINOMAS WITH FARNESYLTRANSFERASE INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 21 Apr 2022
Application
Utility: THERAPIES FOR SQUAMOUS CELL CARCINOMAS External link
Filling date: 6 Sep 2025 Issue date: 10 Mar 2022
Application
Utility: METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 6 Jan 2022
Grant
Utility: Methods of treating cancer patients with farnesyltransferase inhibitors External link
Filling date: 6 Sep 2025 Issue date: 28 Dec 2021
Application
Utility: METHODS OF TREATING CANCER PATIENTS WITH FARNESYLTRANSFERASE INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 9 Dec 2021
Grant
Utility: Methods of treating cancer patients with farnesyltransferase inhibitors External link
Filling date: 6 Sep 2025 Issue date: 21 Sep 2021
Application
Utility: SYNTHESIS OF TIPIFARNIB External link
Filling date: 6 Sep 2025 Issue date: 12 Aug 2021
Grant
Utility: Methods of treating cancer with farnesyltransferase inhibitors External link
Filling date: 6 Sep 2025 Issue date: 20 Apr 2021
Application
Utility: BRIDGED BICYCLIC INHIBITORS OF MENIN-MLL AND METHODS OF USE External link
Filling date: 6 Sep 2025 Issue date: 15 Apr 2021
Application
Utility: SUBSTITUTED INHIBITORS OF MENIN-MLL AND METHODS OF USE External link
Filling date: 6 Sep 2025 Issue date: 8 Apr 2021
Grant
Utility: Methods of treating cancer with farnesyltransferase inhibitors External link
Filling date: 6 Sep 2025 Issue date: 20 Oct 2020
Grant
Utility: Substituted inhibitors of menin-MLL and methods of use External link
Filling date: 6 Sep 2025 Issue date: 22 Sep 2020
Grant
Utility: Bridged bicyclic inhibitors of menin-MLL and methods of use External link
Filling date: 6 Sep 2025 Issue date: 25 Aug 2020
Application
Utility: METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 6 Aug 2020
Application
Utility: SUBSTITUTED INHIBITORS OF MENIN-MLL AND METHODS OF USE External link
Filling date: 6 Sep 2025 Issue date: 9 Jul 2020
Application
Utility: METHODS AND COMPOSITIONS FOR INHIBITING THE INTERACTION OF MENIN WITH MLL PROTEINS External link
Filling date: 6 Sep 2025 Issue date: 28 May 2020
Grant
Utility: Methods and compositions for inhibiting the interaction of menin with MLL proteins External link
Filling date: 6 Sep 2025 Issue date: 17 Mar 2020
Application
Utility: METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 2 Jan 2020
Application
Utility: METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS External link
Filling date: 6 Sep 2025 Issue date: 2 Jan 2020
Grant
Utility: Methods of treating cancer patients with farnesyltransferase inhibitors External link
Filling date: 6 Sep 2025 Issue date: 12 Nov 2019
Grant
Utility: Methods of treating cancer with farnesyltransferase inhibitors External link
Filling date: 6 Sep 2025 Issue date: 1 Oct 2019
Application
Utility: INHIBITORS OF ERK AND METHODS OF USE External link
Filling date: 6 Sep 2025 Issue date: 26 Sep 2019

Showing 1 to 25 of 25 patents.